Expansion to Spectrum range
During the recent BioProcess International US West conference in San Diego, Spectrum Chemical announced an expansion of its BioCertified line of products that undergo complete lot analysis including expanded testing for endotoxin, bioburden and elemental impurities.
This brings the total in the BioCertified range to about 100. The new products include:
* An expanded line of biological buffers, which are used in modelling biological systems, cell culture, bioprocessing, purification and formulation
* Amino acids for protein purification and formulations
* Sugars and carbohydrates to stabilise proteins and prevent damage during cell culture and final fill
* pH adjusters, such as sodium hydroxide pellets to help neutralise acids
RELATED ARTICLES
Two CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.
Biosynth, which supplies critical raw materials and services for diagnostics, vaccines and pharmaceuticals, has officially opened its Biosynth Biological Technology site at Lifebay, a technology park in Suzhou, China.
At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitional year in 2023.
At CPHI in Milan in October, eight Indian CDMOs announced that they have formed a trade group to raise the profile of India’s drug services sector and make it a destination of choice.
CatSci has opened a second oligonucleotides laboratory, which it will use “to introduce novel workflows for the rapid production of vast numbers of oligos at a scale optimised for rapid screening”.
Swedish-based CDMO Recipharm announced at CPHI that it is “expanding its pharmaceutical development capabilities through targeted investments and the integration of cutting-edge technologies”.
